title: [Epidemiologic study of anti-HCV antibodies in Tunisian blood donors].
abstract: A study carried out on 2,006 Tunisian blood donors permitted us to evaluate the prevalence of hepatitis C virus antibodies (anti-HCV) which was 1.09%; frequency of indirect markers of NANBH were as follows: ALAT greater than 2 N (1.24%), anti-HBc (30.35%), 55.5% of HCV (+) donors had anti-HBc (+), 12.5% had rises ALAT and only 33.3% both markers.
authors.affiliation: Centre National de Transfusion sanguine, Tunis.
authors.forename: H
authors.initials: H
authors.lastname: Slama
authors.forename: N
authors.initials: N
authors.lastname: Mojaat
authors.forename: R
authors.initials: R
authors.lastname: Dahri
authors.forename: K
authors.initials: K
authors.lastname: Boukef
mesh_terms: D001782:Blood Donors; D016174:Hepacivirus / Q000276:immunology*; D006508:Hepatitis Antibodies / Q000032:analysis*; D006526:Hepatitis C / Q000453:epidemiology*; D006801:Humans; D014416:Tunisia / Q000208:ethnology
chemical_list: D006508:Hepatitis Antibodies
vernacular_title: Etude épidémiologique des anticorps anti-HCV chez les donneurs de sang en Tunisie.